MAPK9 and breast cancer: JNK2 inhibited the expression of epidermal growth factor receptor pathway substrate 8 (EPS8), which controlled the actin-based motility and were involved in regulating Rac-mediated cell migration, to promote the migration of mammary tumor cells [15–18].